| Chemical conjugation strategies for the development of protein-based subunit nanovaccines L Lu, VT Duong, AO Shalash, M Skwarczynski, I Toth Vaccines 9 (6), 563, 2021 | 55 | 2021 |
| A neoantigen-based peptide vaccine for patients with advanced pancreatic cancer refractory to standard treatment Z Chen, S Zhang, N Han, J Jiang, Y Xu, D Ma, L Lu, X Guo, M Qiu, ... Frontiers in Immunology 12, 691605, 2021 | 40 | 2021 |
| Multi-epitope vaccine design using an immunoinformatic approach for SARS-CoV-2 Y Feng, H Jiang, M Qiu, L Liu, S Zou, Y Li, Q Guo, N Han, Y Sun, K Wang, ... Pathogens 10 (6), 737, 2021 | 15 | 2021 |
| Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy J Shou, F Mo, S Zhang, L Lu, N Han, L Liu, M Qiu, H Li, W Han, D Ma, ... Frontiers in immunology 13, 1000681, 2022 | 12 | 2022 |
| Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape P Koirala, SPR Chen, JC Boer, ZG Khalil, C Deceneux, G Goodchild, L Lu, ... Advanced Functional Materials 33 (12), 2209304, 2023 | 8 | 2023 |
| Liposomal Formulations of a Polyleucine–Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer FZ Firdaus, S Bartlett, WM Hussein, L Lu, Q Wright, W Huang, UJ Nahar, ... Pharmaceutics 15 (2), 602, 2023 | 6 | 2023 |
| Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines. Vaccines 2021, 9, 563 L Lu, VT Duong, AO Shalash, M Skwarczynski, I Toth s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021 | 6 | 2021 |
| Utilizing murine dendritic cell line DC2. 4 to evaluate the immunogenicity of subunit vaccines in vitro L Lu, WY Kong, J Zhang, F Firdaus, JW Wells, RJ Stephenson, I Toth, ... Frontiers in Immunology 15, 1298721, 2024 | 1 | 2024 |
| Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant UJ Nahar, J Wang, AO Shalash, L Lu, MT Islam, N Alharbi, P Koirala, ... Vaccine, 2024 | | 2024 |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets L Liu, L Lu, M Qiu, N Han, S Dai, S Shi, S He, J Zhang, Q Yan, S Chen International Wound Journal 21 (1), e14384, 2024 | | 2024 |
| Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy. Y Fang, J Shou, F Mo, S Zhang, L Lu, N Han, L Liu, M Qiu, H Li, W Han, ... Journal of Clinical Oncology 40 (16_suppl), 3151-3151, 2022 | | 2022 |
